Denali Advisors LLC Reduces Stake in Leidos Holdings, Inc. (NYSE:LDOS)

Denali Advisors LLC decreased its holdings in shares of Leidos Holdings, Inc. (NYSE:LDOS) by 22.6% in the 2nd quarter, Holdings Channel.com reports. The firm owned 1,400 shares of the aerospace company’s stock after selling 409 shares during the quarter. Denali Advisors LLC’s holdings in Leidos were worth $204,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Key Financial Inc lifted its position in shares of Leidos by 6.5% during the 2nd quarter. Key Financial Inc now owns 1,141 shares of the aerospace company’s stock worth $166,000 after buying an additional 70 shares during the last quarter. Bleakley Financial Group LLC raised its stake in Leidos by 2.9% during the 1st quarter. Bleakley Financial Group LLC now owns 2,671 shares of the aerospace company’s stock worth $350,000 after acquiring an additional 76 shares in the last quarter. Somerset Trust Co lifted its position in Leidos by 4.7% in the second quarter. Somerset Trust Co now owns 2,346 shares of the aerospace company’s stock valued at $342,000 after acquiring an additional 106 shares during the last quarter. UMB Bank n.a. boosted its stake in Leidos by 3.1% in the second quarter. UMB Bank n.a. now owns 3,569 shares of the aerospace company’s stock valued at $521,000 after acquiring an additional 107 shares in the last quarter. Finally, Czech National Bank grew its holdings in shares of Leidos by 0.5% during the first quarter. Czech National Bank now owns 24,194 shares of the aerospace company’s stock worth $3,172,000 after purchasing an additional 111 shares during the last quarter. 76.12% of the stock is owned by institutional investors and hedge funds.

Leidos Trading Down 0.3 %

NYSE LDOS opened at $154.34 on Wednesday. The company has a quick ratio of 1.11, a current ratio of 1.21 and a debt-to-equity ratio of 0.91. The stock has a market capitalization of $20.87 billion, a P/E ratio of 66.53, a P/E/G ratio of 1.37 and a beta of 0.70. Leidos Holdings, Inc. has a 52-week low of $89.22 and a 52-week high of $159.10. The firm has a 50-day moving average price of $150.87 and a 200 day moving average price of $142.54.

Leidos (NYSE:LDOS) last issued its earnings results on Tuesday, July 30th. The aerospace company reported $2.63 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.36. Leidos had a return on equity of 28.40% and a net margin of 2.72%. The business had revenue of $4.13 billion during the quarter, compared to the consensus estimate of $4.06 billion. During the same period in the prior year, the business posted $1.80 EPS. The company’s revenue for the quarter was up 7.7% on a year-over-year basis. Equities research analysts expect that Leidos Holdings, Inc. will post 8.95 EPS for the current year.

Leidos Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, September 27th. Shareholders of record on Friday, September 13th will be given a dividend of $0.38 per share. The ex-dividend date of this dividend is Friday, September 13th. This represents a $1.52 annualized dividend and a dividend yield of 0.98%. Leidos’s payout ratio is currently 65.52%.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on the company. Royal Bank of Canada boosted their target price on Leidos from $140.00 to $145.00 and gave the company a “sector perform” rating in a report on Wednesday, July 31st. Wells Fargo & Company boosted their price objective on Leidos from $168.00 to $172.00 and gave the company an “overweight” rating in a research note on Thursday, August 1st. Citigroup raised their target price on shares of Leidos from $165.00 to $169.00 and gave the stock a “buy” rating in a research report on Wednesday, July 31st. JPMorgan Chase & Co. lifted their target price on shares of Leidos from $165.00 to $175.00 and gave the company an “overweight” rating in a report on Wednesday, July 31st. Finally, Truist Financial increased their price target on shares of Leidos from $165.00 to $175.00 and gave the stock a “buy” rating in a research note on Thursday, September 5th. Two investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $163.08.

Insider Transactions at Leidos

In related news, Director Gary Stephen May sold 1,000 shares of the firm’s stock in a transaction dated Tuesday, August 13th. The shares were sold at an average price of $144.02, for a total value of $144,020.00. Following the completion of the sale, the director now owns 11,264 shares in the company, valued at $1,622,241.28. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CEO Thomas Arthur Bell purchased 1,712 shares of the company’s stock in a transaction dated Thursday, August 1st. The stock was acquired at an average price of $145.04 per share, for a total transaction of $248,308.48. Following the completion of the transaction, the chief executive officer now directly owns 22,398 shares in the company, valued at approximately $3,248,605.92. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Gary Stephen May sold 1,000 shares of the business’s stock in a transaction dated Tuesday, August 13th. The stock was sold at an average price of $144.02, for a total transaction of $144,020.00. Following the completion of the sale, the director now owns 11,264 shares in the company, valued at $1,622,241.28. The disclosure for this sale can be found here. Corporate insiders own 0.96% of the company’s stock.

Leidos Company Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.